These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4277694)

  • 1. The effect of Dantrium on spasticity in multiple sclerosis.
    Ladd H; Oist C; Jonsson B
    Acta Neurol Scand; 1974; 50(4):397-408. PubMed ID: 4277694
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of dantrolene sodium on spasticity in multiple sclerosis.
    Gelenberg AJ; Poskanzer DC
    Neurology; 1973 Dec; 23(12):1313-5. PubMed ID: 4796610
    [No Abstract]   [Full Text] [Related]  

  • 3. [Attenuating effect of a new pharmacological agent (Dantrolene sodium) on spasticity].
    Ladd HW; Gingras G; Boucher J; Kazdan N; Keenan R
    Union Med Can; 1973 May; 102(5):1087-92. PubMed ID: 4576244
    [No Abstract]   [Full Text] [Related]  

  • 4. Dantrolene sodium for treatment of spasticity.
    Med Lett Drugs Ther; 1974 Jul; 16(15):61-2. PubMed ID: 4843632
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of a muscle relaxant: dantrolene sodium (Dantrium).
    Dykes MH
    JAMA; 1975 Feb; 231(8):862-4. PubMed ID: 1089167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spasticity and the effect of dantrolene sodium.
    Monster AW
    Arch Phys Med Rehabil; 1974 Aug; 55(8):373-83. PubMed ID: 4605132
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study of sodium dantroline (Dantrium) in multiple sclerosis (author's transl)].
    Gonsette RE; Capart T; Demonty L
    Acta Neurol Belg; 1978; 78(3):141-7. PubMed ID: 352084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Treatment Using Intravenous Dantrolene Sodium for Postoperative Exacerbated Spasticity in Multiple Sclerosis: A Case Report.
    Sturgill EL; Wittwer RL
    A A Pract; 2018 Jul; 11(1):25-27. PubMed ID: 29851691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dantrium in the treatment of increased muscle tonus in patients with multiple sclerosis].
    Cendrowski W
    Neurol Neurochir Pol; 1977; 11(1):117-21. PubMed ID: 320494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dantrolene sodium: long-term effects in severe spasticity.
    Chyatte SB; Basmajian JV
    Arch Phys Med Rehabil; 1973 Jul; 54(7):311-5. PubMed ID: 4577936
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of Dantrium on spasticity in spinal cord injuries.
    Jonsson B; Ladd H; Dahllöf AG
    Scand J Rehabil Med; 1975; 7(2):61-4. PubMed ID: 1162300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative study for assessing the effects of a pharmacological agent on spasticity.
    Monster AW; Herman R; Meeks S; McHenry J
    Am J Phys Med; 1973 Aug; 52(4):163-88. PubMed ID: 4722384
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of dantrolene sodium and diazepam in the treatment of spasticity.
    Schmidt RT; Lee RH; Spehlmann R
    J Neurol Neurosurg Psychiatry; 1976 Apr; 39(4):350-6. PubMed ID: 778344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode of action of dantrolene sodium in spasticity.
    Mai J; Pedersen E
    Acta Neurol Scand; 1979 Jun; 59(6):309-16. PubMed ID: 158280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.
    Pinder RM; Brogden RN; Speight TM; Avery GS
    Drugs; 1977 Jan; 13(1):3-23. PubMed ID: 318989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of dantrolene sodium in relation to blood levels in spastic patients after prolonged administration.
    Meyler WJ; Bakker H; Kok JJ; Agoston S; Wesseling H
    J Neurol Neurosurg Psychiatry; 1981 Apr; 44(4):334-9. PubMed ID: 7241161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of dantrolene sodium and diazepam in the treatment of spasticity.
    Glass A; Hannah A
    Paraplegia; 1974 Nov; 12(3):170-4. PubMed ID: 4616209
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of Dantrium on spasticity in paraplegic and tetraplegic patients (author's transl)].
    van Laere M; Leus P; Mastelinck C
    J Belge Med Phys Rehabil; 1978; 1(2):189-99. PubMed ID: 757420
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathogenetic therapy of spasticity].
    Kasatkin DS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):80-5. PubMed ID: 18697257
    [No Abstract]   [Full Text] [Related]  

  • 20. Dantrium--torque induced motion ("TIM"). Analysis in normal subjects.
    Walsh EG
    Agressologie; 1977; 18 Spec No():31-3. PubMed ID: 900358
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.